CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial

<p>Abstract</p> <p>Background</p> <p>Worldwide, over 10 million people are killed or hospitalized because of traumatic brain injury each year. About 90% of deaths occur in low- and middle-income countries. The condition mostly affects young adults, and many experience l...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Dewan Yashbir, Komolafe Edward O, Mejía-Mantilla Jorge H, Perel Pablo, Roberts Ian, Shakur Haleema
Format: Artigo
Jezik:Inglês
Izdano: BMC 2012-06-01
Serija:Trials
Teme:
Antifibrinolytic
Clinical trial
Emergency care
Intracranial bleeding
Tranexamic acid
Traumatic brain injury
Online pristup:http://www.trialsjournal.com/content/13/1/87
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items